カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界の豚熱生ワクチン市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Classical Swine Fever Live Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23AG11369）・商品コード：GIR23AG11369
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年8月
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の豚熱生ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の豚熱生ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 豚熱生ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

豚熱生ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・組織培養由来、細胞株由来

用途別セグメント
・市場売却、政府入札

主要な市場プレーヤー
・WINSUN、Boehringer Ingelheim、CAHIC、SPAH、Merck、Ceva、Harbin Veterinary Research Institute、Qilu Animal Health Products Factory、Ringpu Biology、DHN、CAVAC、Komipharm、Agrovet、Bioveta、Jinyu Bio-Technology、Institutul Pasteur、MVP、Tecon

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、豚熱生ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚熱生ワクチンメーカーの企業概要、2019年～2022年までの豚熱生ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚熱生ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別豚熱生ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの豚熱生ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での豚熱生ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および豚熱生ワクチンの産業チェーンを掲載しています。
・第14、15章では、豚熱生ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 豚熱生ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：組織培養由来、細胞株由来
– 用途別分析（2018年vs2022年vs2029年）：市場売却、政府入札
– 世界の豚熱生ワクチン市場規模・予測
– 世界の豚熱生ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– WINSUN、Boehringer Ingelheim、CAHIC、SPAH、Merck、Ceva、Harbin Veterinary Research Institute、Qilu Animal Health Products Factory、Ringpu Biology、DHN、CAVAC、Komipharm、Agrovet、Bioveta、Jinyu Bio-Technology、Institutul Pasteur、MVP、Tecon
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：組織培養由来、細胞株由来
・用途別分析2018年-2029年：市場売却、政府入札
・豚熱生ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚熱生ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚熱生ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚熱生ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・豚熱生ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Classical Swine Fever Live Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Classical Swine Fever Live Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tissue Culture Origin
1.3.3 Cell Line Origin
1.4 Market Analysis by Application
1.4.1 Overview: Global Classical Swine Fever Live Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Market Sales
1.4.3 Government Tender
1.5 Global Classical Swine Fever Live Vaccine Market Size & Forecast
1.5.1 Global Classical Swine Fever Live Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Classical Swine Fever Live Vaccine Sales Quantity (2018-2029)
1.5.3 Global Classical Swine Fever Live Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 WINSUN
2.1.1 WINSUN Details
2.1.2 WINSUN Major Business
2.1.3 WINSUN Classical Swine Fever Live Vaccine Product and Services
2.1.4 WINSUN Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 WINSUN Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Classical Swine Fever Live Vaccine Product and Services
2.2.4 Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 CAHIC
2.3.1 CAHIC Details
2.3.2 CAHIC Major Business
2.3.3 CAHIC Classical Swine Fever Live Vaccine Product and Services
2.3.4 CAHIC Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CAHIC Recent Developments/Updates
2.4 SPAH
2.4.1 SPAH Details
2.4.2 SPAH Major Business
2.4.3 SPAH Classical Swine Fever Live Vaccine Product and Services
2.4.4 SPAH Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SPAH Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Classical Swine Fever Live Vaccine Product and Services
2.5.4 Merck Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merck Recent Developments/Updates
2.6 Ceva
2.6.1 Ceva Details
2.6.2 Ceva Major Business
2.6.3 Ceva Classical Swine Fever Live Vaccine Product and Services
2.6.4 Ceva Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ceva Recent Developments/Updates
2.7 Harbin Veterinary Research Institute
2.7.1 Harbin Veterinary Research Institute Details
2.7.2 Harbin Veterinary Research Institute Major Business
2.7.3 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product and Services
2.7.4 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Harbin Veterinary Research Institute Recent Developments/Updates
2.8 Qilu Animal Health Products Factory
2.8.1 Qilu Animal Health Products Factory Details
2.8.2 Qilu Animal Health Products Factory Major Business
2.8.3 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product and Services
2.8.4 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Qilu Animal Health Products Factory Recent Developments/Updates
2.9 Ringpu Biology
2.9.1 Ringpu Biology Details
2.9.2 Ringpu Biology Major Business
2.9.3 Ringpu Biology Classical Swine Fever Live Vaccine Product and Services
2.9.4 Ringpu Biology Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ringpu Biology Recent Developments/Updates
2.10 DHN
2.10.1 DHN Details
2.10.2 DHN Major Business
2.10.3 DHN Classical Swine Fever Live Vaccine Product and Services
2.10.4 DHN Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 DHN Recent Developments/Updates
2.11 CAVAC
2.11.1 CAVAC Details
2.11.2 CAVAC Major Business
2.11.3 CAVAC Classical Swine Fever Live Vaccine Product and Services
2.11.4 CAVAC Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CAVAC Recent Developments/Updates
2.12 Komipharm
2.12.1 Komipharm Details
2.12.2 Komipharm Major Business
2.12.3 Komipharm Classical Swine Fever Live Vaccine Product and Services
2.12.4 Komipharm Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Komipharm Recent Developments/Updates
2.13 Agrovet
2.13.1 Agrovet Details
2.13.2 Agrovet Major Business
2.13.3 Agrovet Classical Swine Fever Live Vaccine Product and Services
2.13.4 Agrovet Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Agrovet Recent Developments/Updates
2.14 Bioveta
2.14.1 Bioveta Details
2.14.2 Bioveta Major Business
2.14.3 Bioveta Classical Swine Fever Live Vaccine Product and Services
2.14.4 Bioveta Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bioveta Recent Developments/Updates
2.15 Jinyu Bio-Technology
2.15.1 Jinyu Bio-Technology Details
2.15.2 Jinyu Bio-Technology Major Business
2.15.3 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product and Services
2.15.4 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jinyu Bio-Technology Recent Developments/Updates
2.16 Institutul Pasteur
2.16.1 Institutul Pasteur Details
2.16.2 Institutul Pasteur Major Business
2.16.3 Institutul Pasteur Classical Swine Fever Live Vaccine Product and Services
2.16.4 Institutul Pasteur Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Institutul Pasteur Recent Developments/Updates
2.17 MVP
2.17.1 MVP Details
2.17.2 MVP Major Business
2.17.3 MVP Classical Swine Fever Live Vaccine Product and Services
2.17.4 MVP Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 MVP Recent Developments/Updates
2.18 Tecon
2.18.1 Tecon Details
2.18.2 Tecon Major Business
2.18.3 Tecon Classical Swine Fever Live Vaccine Product and Services
2.18.4 Tecon Classical Swine Fever Live Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Tecon Recent Developments/Updates
3 Competitive Environment: Classical Swine Fever Live Vaccine by Manufacturer
3.1 Global Classical Swine Fever Live Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Classical Swine Fever Live Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Classical Swine Fever Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Classical Swine Fever Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Classical Swine Fever Live Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Classical Swine Fever Live Vaccine Manufacturer Market Share in 2022
3.5 Classical Swine Fever Live Vaccine Market: Overall Company Footprint Analysis
3.5.1 Classical Swine Fever Live Vaccine Market: Region Footprint
3.5.2 Classical Swine Fever Live Vaccine Market: Company Product Type Footprint
3.5.3 Classical Swine Fever Live Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Classical Swine Fever Live Vaccine Market Size by Region
4.1.1 Global Classical Swine Fever Live Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Classical Swine Fever Live Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Classical Swine Fever Live Vaccine Average Price by Region (2018-2029)
4.2 North America Classical Swine Fever Live Vaccine Consumption Value (2018-2029)
4.3 Europe Classical Swine Fever Live Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value (2018-2029)
4.5 South America Classical Swine Fever Live Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Classical Swine Fever Live Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Classical Swine Fever Live Vaccine Consumption Value by Type (2018-2029)
5.3 Global Classical Swine Fever Live Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Classical Swine Fever Live Vaccine Consumption Value by Application (2018-2029)
6.3 Global Classical Swine Fever Live Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Classical Swine Fever Live Vaccine Market Size by Country
7.3.1 North America Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Classical Swine Fever Live Vaccine Market Size by Country
8.3.1 Europe Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Classical Swine Fever Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Classical Swine Fever Live Vaccine Market Size by Country
10.3.1 South America Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Classical Swine Fever Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Classical Swine Fever Live Vaccine Market Drivers
12.2 Classical Swine Fever Live Vaccine Market Restraints
12.3 Classical Swine Fever Live Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Classical Swine Fever Live Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Classical Swine Fever Live Vaccine
13.3 Classical Swine Fever Live Vaccine Production Process
13.4 Classical Swine Fever Live Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Classical Swine Fever Live Vaccine Typical Distributors
14.3 Classical Swine Fever Live Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Classical Swine Fever Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Classical Swine Fever Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. WINSUN Basic Information, Manufacturing Base and Competitors
Table 4. WINSUN Major Business
Table 5. WINSUN Classical Swine Fever Live Vaccine Product and Services
Table 6. WINSUN Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. WINSUN Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Classical Swine Fever Live Vaccine Product and Services
Table 11. Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. CAHIC Basic Information, Manufacturing Base and Competitors
Table 14. CAHIC Major Business
Table 15. CAHIC Classical Swine Fever Live Vaccine Product and Services
Table 16. CAHIC Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CAHIC Recent Developments/Updates
Table 18. SPAH Basic Information, Manufacturing Base and Competitors
Table 19. SPAH Major Business
Table 20. SPAH Classical Swine Fever Live Vaccine Product and Services
Table 21. SPAH Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. SPAH Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Classical Swine Fever Live Vaccine Product and Services
Table 26. Merck Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merck Recent Developments/Updates
Table 28. Ceva Basic Information, Manufacturing Base and Competitors
Table 29. Ceva Major Business
Table 30. Ceva Classical Swine Fever Live Vaccine Product and Services
Table 31. Ceva Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ceva Recent Developments/Updates
Table 33. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 34. Harbin Veterinary Research Institute Major Business
Table 35. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product and Services
Table 36. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Harbin Veterinary Research Institute Recent Developments/Updates
Table 38. Qilu Animal Health Products Factory Basic Information, Manufacturing Base and Competitors
Table 39. Qilu Animal Health Products Factory Major Business
Table 40. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product and Services
Table 41. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Qilu Animal Health Products Factory Recent Developments/Updates
Table 43. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 44. Ringpu Biology Major Business
Table 45. Ringpu Biology Classical Swine Fever Live Vaccine Product and Services
Table 46. Ringpu Biology Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ringpu Biology Recent Developments/Updates
Table 48. DHN Basic Information, Manufacturing Base and Competitors
Table 49. DHN Major Business
Table 50. DHN Classical Swine Fever Live Vaccine Product and Services
Table 51. DHN Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. DHN Recent Developments/Updates
Table 53. CAVAC Basic Information, Manufacturing Base and Competitors
Table 54. CAVAC Major Business
Table 55. CAVAC Classical Swine Fever Live Vaccine Product and Services
Table 56. CAVAC Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CAVAC Recent Developments/Updates
Table 58. Komipharm Basic Information, Manufacturing Base and Competitors
Table 59. Komipharm Major Business
Table 60. Komipharm Classical Swine Fever Live Vaccine Product and Services
Table 61. Komipharm Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Komipharm Recent Developments/Updates
Table 63. Agrovet Basic Information, Manufacturing Base and Competitors
Table 64. Agrovet Major Business
Table 65. Agrovet Classical Swine Fever Live Vaccine Product and Services
Table 66. Agrovet Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Agrovet Recent Developments/Updates
Table 68. Bioveta Basic Information, Manufacturing Base and Competitors
Table 69. Bioveta Major Business
Table 70. Bioveta Classical Swine Fever Live Vaccine Product and Services
Table 71. Bioveta Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Bioveta Recent Developments/Updates
Table 73. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 74. Jinyu Bio-Technology Major Business
Table 75. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product and Services
Table 76. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jinyu Bio-Technology Recent Developments/Updates
Table 78. Institutul Pasteur Basic Information, Manufacturing Base and Competitors
Table 79. Institutul Pasteur Major Business
Table 80. Institutul Pasteur Classical Swine Fever Live Vaccine Product and Services
Table 81. Institutul Pasteur Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Institutul Pasteur Recent Developments/Updates
Table 83. MVP Basic Information, Manufacturing Base and Competitors
Table 84. MVP Major Business
Table 85. MVP Classical Swine Fever Live Vaccine Product and Services
Table 86. MVP Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. MVP Recent Developments/Updates
Table 88. Tecon Basic Information, Manufacturing Base and Competitors
Table 89. Tecon Major Business
Table 90. Tecon Classical Swine Fever Live Vaccine Product and Services
Table 91. Tecon Classical Swine Fever Live Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Tecon Recent Developments/Updates
Table 93. Global Classical Swine Fever Live Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Classical Swine Fever Live Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Classical Swine Fever Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 96. Market Position of Manufacturers in Classical Swine Fever Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Classical Swine Fever Live Vaccine Production Site of Key Manufacturer
Table 98. Classical Swine Fever Live Vaccine Market: Company Product Type Footprint
Table 99. Classical Swine Fever Live Vaccine Market: Company Product Application Footprint
Table 100. Classical Swine Fever Live Vaccine New Market Entrants and Barriers to Market Entry
Table 101. Classical Swine Fever Live Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Classical Swine Fever Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Classical Swine Fever Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Classical Swine Fever Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Classical Swine Fever Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Classical Swine Fever Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 107. Global Classical Swine Fever Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 108. Global Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Classical Swine Fever Live Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Classical Swine Fever Live Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Classical Swine Fever Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 113. Global Classical Swine Fever Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 114. Global Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Classical Swine Fever Live Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Classical Swine Fever Live Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Classical Swine Fever Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 119. Global Classical Swine Fever Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 120. North America Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Classical Swine Fever Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Classical Swine Fever Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Classical Swine Fever Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Classical Swine Fever Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Classical Swine Fever Live Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Classical Swine Fever Live Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Classical Swine Fever Live Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Classical Swine Fever Live Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Classical Swine Fever Live Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Classical Swine Fever Live Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Classical Swine Fever Live Vaccine Raw Material
Table 161. Key Manufacturers of Classical Swine Fever Live Vaccine Raw Materials
Table 162. Classical Swine Fever Live Vaccine Typical Distributors
Table 163. Classical Swine Fever Live Vaccine Typical Customers
List of Figures
Figure 1. Classical Swine Fever Live Vaccine Picture
Figure 2. Global Classical Swine Fever Live Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Tissue Culture Origin Examples
Figure 5. Cell Line Origin Examples
Figure 6. Global Classical Swine Fever Live Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Market Sales Examples
Figure 9. Government Tender Examples
Figure 10. Global Classical Swine Fever Live Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Classical Swine Fever Live Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Classical Swine Fever Live Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Classical Swine Fever Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Classical Swine Fever Live Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Classical Swine Fever Live Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Classical Swine Fever Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Classical Swine Fever Live Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Classical Swine Fever Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Classical Swine Fever Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Classical Swine Fever Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Classical Swine Fever Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Classical Swine Fever Live Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Classical Swine Fever Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Classical Swine Fever Live Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Classical Swine Fever Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Classical Swine Fever Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Classical Swine Fever Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Classical Swine Fever Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Classical Swine Fever Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Classical Swine Fever Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Classical Swine Fever Live Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Classical Swine Fever Live Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Classical Swine Fever Live Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Classical Swine Fever Live Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Classical Swine Fever Live Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Classical Swine Fever Live Vaccine Market Drivers
Figure 73. Classical Swine Fever Live Vaccine Market Restraints
Figure 74. Classical Swine Fever Live Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Classical Swine Fever Live Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Classical Swine Fever Live Vaccine
Figure 78. Classical Swine Fever Live Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


★調査レポート[世界の豚熱生ワクチン市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23AG11369)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の豚熱生ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の豚連鎖球菌ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のデング熱検査キット市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 豚コレラウイルス検出キットのグローバル市場展望 2023年-2029年：サンプルサイズ25、サンプルサイズ50
  • 世界の経口コレラワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のmRNA新型コロナウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の牛疫ウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆